Founded by Cambridge neuroscience PhDs, Callosum claims its multi‑chip AI scheduler can boost enterprise task accuracy, speed, and cost efficiency through cross‑vendor hardware optimization.
London‑based AI startup Callosum has raised $10.25 million in a round led by Plural with ARIA R&D support. Founded by two Cambridge neuroscience PhDs, Callosum develops software to schedule AI workloads across Nvidia, AMD, AWS, Cerebras, and SambaNova chips. The system reportedly delivers 2× higher accuracy, 7× faster processing, and 4× lower costs for complex enterprise tasks.